Style | Citing Format |
---|---|
MLA | Miri M, et al.. "Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility." Medical Oncology, vol. 29, no. 3, 2012, pp. 1581-1585. |
APA | Miri M, Hemati S, Safari F, Tavassoli M (2012). Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility. Medical Oncology, 29(3), 1581-1585. |
Chicago | Miri M, Hemati S, Safari F, Tavassoli M. "Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility." Medical Oncology 29, no. 3 (2012): 1581-1585. |
Harvard | Miri M et al. (2012) 'Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility', Medical Oncology, 29(3), pp. 1581-1585. |
Vancouver | Miri M, Hemati S, Safari F, Tavassoli M. Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility. Medical Oncology. 2012;29(3):1581-1585. |
BibTex | @article{ author = {Miri M and Hemati S and Safari F and Tavassoli M}, title = {Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility}, journal = {Medical Oncology}, volume = {29}, number = {3}, pages = {1581-1585}, year = {2012} } |
RIS | TY - JOUR AU - Miri M AU - Hemati S AU - Safari F AU - Tavassoli M TI - Ggcn Polymorphism of Erf3a/Gspt1 Gene and Breast Cancer Susceptibility JO - Medical Oncology VL - 29 IS - 3 SP - 1581 EP - 1585 PY - 2012 ER - |